Dergiler / Diagnostic and Interventional Radiology / 2015 / Cilt: 21 - Sayı: 2

Accessory hepatic vein recanalization for treatment of Budd-Chiari syndrome due to long-segment obstruction of the hepatic vein: initial clinical experience

Sayfa
148–153
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

For patients with a compensatory but obstructed accessory hepatic vein, recanalization is a simple, safe, and effective treatment optio

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:PURPOSEWe aimed to investigate the feasibility and effectiveness of accessory hepatic vein recanalization (balloon dilatation/stent insertion) for patients with Budd-Chiari syndrome (BCS) due to long-segment obstruction of the hepatic vein.
📊
Temel Bulgular & Veri:METHODS From March 2010 to December 2013, 20 consecutive pa-tients with BCS, due to long-segment obstruction of three hepatic veins, treated with accessory hepatic vein recanaliza-tion (11 males, 9 females; mean age, 33.4±10.9 years; range, 22-56 years) were included in this retrospective study.
💡
Sonuç & Katkı:For patients with a compensatory but obstructed accessory hepatic vein, recanalization is a simple, safe, and effective treatment optio
🔬Tür:Araştırma Makalesi
📍Kapsam:2010 Verileri
⚙️Değişkenler:Alan Parametreleri

Abstract

PURPOSEWe aimed to investigate the feasibility and effectiveness of accessory hepatic vein recanalization (balloon dilatation/stent insertion) for patients with Budd-Chiari syndrome (BCS) due to long-segment obstruction of the hepatic vein. METHODS From March 2010 to December 2013, 20 consecutive pa-tients with BCS, due to long-segment obstruction of three hepatic veins, treated with accessory hepatic vein recanaliza-tion (11 males, 9 females; mean age, 33.4±10.9 years; range, 22-56 years) were included in this retrospective study. Data on technical success, clinical success, and follow-up were col-lected and analyzed. RESULTS Technical and clinical success was achieved in all patients. Each patient was managed with a single accessory hepatic vein recanalization procedure. No procedure-related com-plications occurred. The diameter of the accessory hepatic vein was 8.45±1.47 mm (6-11 mm) at the stem, and there were many collateral circulations between the hepatic vein and the accessory hepatic vein. The mean pressure of acces-sory hepatic vein decreased from 47.50±5.59 cm H2O be-fore treatment to 28.80±3.47 cm H2O after treatment (P < 0.001). Abnormal levels of total bilirubin, albumin, aspartate aminotransferase, and alanine transaminase improved after the treatment. During the follow-up, three patients experi-enced restenosis or stenting of the accessory hepatic vein. CONCLUSIONS In BCS due to long-segment obstruction of the hepatic veins, it is important to confirm whether there is a compensatory accessory hepatic vein. For patients with a compensatory but obstructed accessory hepatic vein, recanalization is a simple, safe, and effective treatment optio

🔖

Bu Makaleye Atıf Yap

FU, Y., XU, H., ZHANG, K., ZHANG, Q., WEİ, N. (2015). Accessory hepatic vein recanalization for treatment of Budd-Chiari syndrome due to long-segment obstruction of the hepatic vein: initial clinical experience. Diagnostic and Interventional Radiology, Cilt: 21 - Sayı: 2, 148–153. https://ajindex.com/articles/213053

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (5)

  1. Zhang CQ, Fu LN, Xu L, et al. Long-term effect of stent placement in 115 patients with Budd-Chiari syndrome. World J Gas- troenterol 2003; 9:2587-2591.
  2. Li T, Zhai S, Pang Z, et al. Feasibility and midterm outcomes of percutaneous tran- shepatic balloon angioplasty for symp- tomatic Budd-Chiari syndrome secondary to hepatic venous obstruction. J Vasc Surg 2009; 50:1079-1084. [CrossRef] Langlet P, Valla D. Is surgical portosys- temic shunt the treatment of choice in Budd-Chiari syndrome? Acta Gastroen- terol Belg 2002; 65:155-160.
  3. Neumann AB, Andersen SD, Nielsen DT, Holland-Fischer P, Vilstrup H, Grİnbæk H. Treatment of Budd-Chiari syndrome with a focus on transjugular intrahepat- ic portosystemic shunt. World J Hepatol 2013; 5:38-42. [CrossRef] Miraglia R, Maruzzelli L, Luca A. Recanal- ization of occlusive transjugular intrahe- patic portosystemic shunts inaccessible to the standard transvenous approach. Diagn Interv Radiol 2013; 19:61-65.
  4. Soyama A, Eguchi S, Yanaga K, Takatsuki M, Hidaka M, Kanematsu T. Living donor liver transplantation with extensive ca- val thrombectomy for acute-on-chronic Budd-Chiari syndrome. Surg Today 2011; 41:1026-1028. [CrossRef] Gao Y, Chen S, Yu C. Applicability of different endovascular methods for treat- ment of refractory Budd-Chiari syndrome. Cell Biochem Biophys 2011; 61:453-460. [CrossRef] Han G, Qi X, Zhang W, et al. Percutane- ous recanalization for Budd-Chiari syn- drome: an 11-year retrospective study on patency and survival in 177 Chinese patients from a single center. Radiology 2013; 266:657-667. [CrossRef] Beckett D, Olliff S. Interventional radiol- ogy in the management of Budd Chiari syndrome. Cardiovasc Intervent Radiol 2008; 31:839-847. [CrossRef] Eapen CE, Velissaris D, Heydtmann M, et al. Favourable medium term outcome fol- lowing hepatic vein recanalisation and/or transjugular intrahepatic portosystemic shunt for Budd Chiari syndrome. Gut 2006; 55:878-884. [CrossRef] Parvinian A, Bui JT, Knuttinen MG, Mino- cha J, Gaba RC. Transjugular intrahepatic portosystemic shunt for the treatment of medically refractory ascites. Diagn Interv Radiol 2014; 20:58-64.
  5. Buhe S, Miyaki T, Saito T, et al. A study of the accessory hepatic vein to segments VI and VII with a morphological recon- sideration of the human liver. Surg Radiol Anat 2008; 30:201-207. [CrossRef] Mammen T, Keshava S, Eapen CE, al. Intrahepatic collateral recanalization in symptomatic Budd-Chiari syndrome: a single-center experience. J Vasc Interv Ra- di